• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts Dermatology

Category Archive

  • Dermatology / March 25, 2021

    Refinement and Validation of the ItchyQoL using Classical Test Theory and Item Response Theory resulted in a reduction of the response categories from a 5-point to a 3-point scale.

    View Post
  • Dermatology / April 4, 2021

    Dermatofibrosarcoma protuberans in pregnancy: a case series and review of the literature.

    View Post
  • Dermatology / November 20, 2020

    Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic non-commercial multicentre randomised open label parallel group medical device trial.

    View Post
  • Dermatology / December 30, 2020

    Hidradenitis Suppurativa and Atopic Dermatitis: A Two-Way Association.

    View Post
  • Dermatology / March 24, 2021

    A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results.

    View Post

Dermoscopy of discoid lupus erythematosus – a systematic review of the literature.

In Dermatology
by ClinOwl
December 15, 2020

Discoid lupus erythematosus (DLE) may lead to disfiguring scarring and permanent hair loss. Dermoscopy may serve as a noninvasive tool useful in the preliminary diagnosis of hair loss and inflammatory …

Cutaneous adverse effects due to personal protective measures during COVID-19 pandemic: a study of 101 patients.

In Dermatology
by ClinOwl
December 15, 2020

Coronavirus Disease 2019 (COVID-19) is a viral illness caused by the novel coronavirus SARS-CoV-2 which spreads via droplets from an infected person. There has been an unprecedented rise in the …

Infantile infection and antibiotic exposure in association with pediatric psoriasis development: a nationwide nested case-control study.

In Dermatology
by ClinOwl
December 15, 2020

Microbiol dysbiosis and antibiotic exposure have been implicated in the pathogenesis of pediatric inflammatory diseases.To investigate the impacts of infantile infection and antibiotic exposure on pediatric psoriasis development METHODS: This …

Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: a Danish nationwide cohort study.

In Dermatology
by ClinOwl
December 15, 2020

Limited data suggest that hydroxychloroquine may affect risk of cardiovascular disease in patients with lupus erythematosus (LE).To investigate whether hydroxychloroquine treatment is associated with major adverse cardiovascular events (MACE) (myocardial …

2020 Annual Report of DataDerm™: The Database of The American Academy of Dermatology (AAD).

In Dermatology
by ClinOwl
December 14, 2020

The American Academy of Dermatology (AAD) launched DataDerm™ in 2016 as the clinical data registry platform of AAD. DataDerm is approved by Centers for Medicare & Medicaid Services (CMS) as …

The British Association of Dermatologists’ Undergraduate Curriculum Update 2021.

In Dermatology
by ClinOwl
December 14, 2020

The General Medical Council (GMC) plans to introduce a national Medical Licensing Assessment (MLA) in 2024 for all UK medical students as part of their primary medical qualification, with dermatology …

The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort.

In Dermatology
by ClinOwl
December 14, 2020

Clinical and histological diagnosis of Sézary syndrome (SS) and mycosis fungoides (MF) is challenging in routine. We investigated five blood markers previously described for SS (T-plastin, Twist, KIR3DL2, NKp46 and …

Why don’t people with psoriasis take enough exercise?

In Dermatology
by ClinOwl
December 14, 2020

Psoriasis is a chronic skin condition which causes red, scaly patches and affects around 2% of the population. People with psoriasis are more likely than others to suffer cardiovascular disease …

Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis.

In Dermatology
by ClinOwl
December 11, 2020

Antibody-based therapies that inhibit pro-inflammatory cytokine signaling are commonly used in dermatology. Paradoxically, these medications may induce or exacerbate inflammatory disorders.To summarize the spectrum of manifestations, incidence, timing, potential mechanisms, …

Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after anti-TNF failure.

In Dermatology
by ClinOwl
December 10, 2020

Dear Editor, hidradenitis suppurativa (HS) is a relapsing inflammatory skin disease. The cytokines IL-1β, IL-12, IL-23, IL-17 and TNF-α are involved in the inflammatory process. The only approved drug for …

  • Page 40 of 57
  • ←
  • 1
  • ...
  • 39
  • 40
  • 41
  • ...
  • 57
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer